TMS for PTSD in Youth (NCT07401225) | Clinical Trial Compass
RecruitingNot Applicable
TMS for PTSD in Youth
United States20 participantsStarted 2026-05-09
Plain-language summary
The purpose of this study is to test whether transcranial magnetic stimulation, or TMS, is an acceptable and helpful treatment for ongoing symptoms of posttraumatic stress syndrome disorder (PTSD) in 12-20 year olds. Ongoing PTSD refers to symptoms that continue after completing trauma-focused psychotherapy. About 1 in 4 patients need additional help to overcome PTSD after completing psychotherapy. Currently, scientists do not know the best way to help adolescents with persistent PTSD, and this study will test TMS as a possible treatment, and hopefully lead to future studies including more people.
Who can participate
Age range12 Years – 20 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Males and females; Age 12-20
✓. Have previously completed at least 9 sessions of trauma-focused therapy in our clinical trial or in the community
✓. Have current self-reported symptom score of 20 or greater on the UCLA PTSD Reaction index
✓. Willing to attend 10 TMS treatment sessions within a 30-day period
✓. Fluent in English
Exclusion criteria
✕. History of seizures
✕. History of head injury with loss of consciousness and concussive sequelae
✕. Brain abnormality such as tumor or other observable abnormality
✕. Currently receiving psychotherapy or TMS treatment
✕. Currently pregnant
✕. MRI contraindications (metal in body, orthodontic braces)
What they're measuring
1
Side Effects of TMS treatment
Timeframe: Day 1 of treatment through Day 30
2
Number of Adverse Events
Timeframe: Day 1 of treatment through Day 30
3
Completion rate of Treatment
Timeframe: Day 1 of treatment through Day 30
Trial details
NCT IDNCT07401225
SponsorThe University of Texas Health Science Center at San Antonio